RHJA
PGNX
Rice Hall James & Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,776,490
| Closed | -$8.98M | – | 289 |
|
|
2019
Q3 | $8.98M | Sell |
1,776,490
-466,013
| -21% | -$2.36M | 0.32% | 105 |
|
|
2019
Q2 | $13.8M | Sell |
2,242,503
-50,676
| -2% | -$313K | 0.46% | 87 |
|
|
2019
Q1 | $10.6M | Buy |
2,293,179
+369,680
| +19% | +$1.72M | 0.34% | 101 |
|
|
2018
Q4 | $8.08M | Buy |
1,923,499
+578,239
| +43% | +$2.43M | 0.29% | 106 |
|
|
2018
Q3 | $8.44M | Sell |
1,345,260
-44,580
| -3% | -$280K | 0.3% | 100 |
|
|
2018
Q2 | $11.2M | Buy |
1,389,840
+15,378
| +1% | +$124K | 0.41% | 85 |
|
|
2018
Q1 | $10.3M | Sell |
1,374,462
-7,945
| -0.6% | -$59.3K | 0.4% | 91 |
|
|
2017
Q4 | $8.23M | Buy |
1,382,407
+67,464
| +5% | +$401K | 0.32% | 97 |
|
|
2017
Q3 | $9.68M | Sell |
1,314,943
-49,936
| -4% | -$368K | 0.43% | 91 |
|
|
2017
Q2 | $9.27M | Buy |
1,364,879
+266,763
| +24% | +$1.81M | 0.4% | 91 |
|
|
2017
Q1 | $10.4M | Sell |
1,098,116
-14,702
| -1% | -$139K | 0.51% | 82 |
|
|
2016
Q4 | $9.62M | Sell |
1,112,818
-16,301
| -1% | -$141K | 0.48% | 84 |
|
|
2016
Q3 | $7.15M | Buy |
1,129,119
+164,322
| +17% | +$1.04M | 0.37% | 91 |
|
|
2016
Q2 | $4.07M | Buy |
964,797
+44,906
| +5% | +$189K | 0.23% | 94 |
|
|
2016
Q1 | $4.01M | Buy |
919,891
+28,219
| +3% | +$123K | 0.23% | 96 |
|
|
2015
Q4 | $5.47M | Buy |
891,672
+409,618
| +85% | +$2.51M | 0.31% | 87 |
|
|
2015
Q3 | $2.76M | Buy |
482,054
+421,104
| +691% | +$2.41M | 0.18% | 127 |
|
|
2015
Q2 | $455K | Buy |
60,950
+7,953
| +15% | +$59.4K | 0.03% | 272 |
|
|
2015
Q1 | $317K | Buy |
52,997
+27,633
| +109% | +$165K | 0.02% | 294 |
|
|
2014
Q4 | $192K | Buy |
+25,364
| New | +$192K | 0.01% | 299 |
|